Newswise — Peter B. Berger, MD, Director of Geisinger's Center for Clinical Studies and an interventional cardiologist at Geisinger's Heart Institute, is featured on Reach MD's Heart Matters program, at XM Satellite Radio Channel 160, beginning Monday, January 26 2009. Dr. Berger, a recognized expert in the field of antiplatelet therapy and stenting, will address controversies related to antiplatelet therapy and stenting.
Hosting Dr. Berger's interview segment is American College of Cardiology President W. Douglas Weaver, MD.
Dr. Berger is a Diplomate of the National Board of Medical Examiners, the American Board of Internal Medicine, the American College of Cardiology and the Board of Internal Medicine (Interventional Cardiology). He is a member of the American Board of Internal Medicine and, in that capacity, helps write the Interventional Cardiology Board Exam. He currently serves, or recently served on the Cath and Interventional Cardiology Committees of the American Heart Association, the American College of Cardiology, and the Society of Coronary Angiography and Intervention. He is a member of numerous professional societies and editorial boards, and has participated in and led dozens of research studies throughout his career.
For specific programming information, or to listen to this program, please go to www.reachmd.com.
About Geisinger Health SystemFounded in 1915, Geisinger Health System is one of the nations largest integrated health services organizations. Serving more than 2.6 million residents throughout central and northeastern Pennsylvania, the physician-led organization is a nationally recognized leader in the use of electronic health records, patient access and engagement in their healthcare, and in medical education for the next generation. Geisinger is comprised of three medical center campuses, a 740-member group practice, a not-for-profit health insurance company and research that extends across our large system- all dedicated to creating new models for scientific discovery, quality patient care, and successful clinical outcomes. Geisinger's Weis Center, Center for Health Research and Center for Clinical Studies include basic science, population-based and clinical trials research, complemented by collaborative relationships with top academic centers. Geisinger Ventures, the system's for profit entrepreneurial arm, seeks and promotes opportunities to speed the delivery of medical innovation to benefit patients. For more information, visit www.geisinger.org.
About ReachMDReach MD is a revolutionary new communication, information and education company designed to engage busy, practicing clinicians and medical professionals everyday. Health care professionals can access ReachMD via XM Satellite Radio, Online and OnDemand (XM subscription not required). ReachMD's unique multi-channel platform allows access to targeted physicians and a broader health care professional audience quickly, frequently and efficiently. ReachMD has attracted the attention of numerous medical societies, associations and academic institutions many of which have become involved in ongoing partnerships with the channel. These partnerships have dramatically accelerated the adoption of ReachMD by the health care community and are in part the reason for the significant level of awareness and positive brand affiliation healthcare professionals have for ReachMD. Over 250,000 health care professionals tune in weekly to ReachMD.
RSS